Highlights from the Updates from ASCO Webinar
Learn about the latest GIST research from ASCO 2026, including updates on two promising clinical trials exploring new strategies to treat advanced GIST and address treatment resistance.
Learn about the latest GIST research from ASCO 2026, including updates on two promising clinical trials exploring new strategies to treat advanced GIST and address treatment resistance.
Dr. Jonathan Trent and Denisse Evans will share how ctDNA can help monitor GIST and guide personalized treatment.
Deciphera issued a press release today sharing the results of an exploratory analysis of data using circulating tumor DNA (ctDNA) from the INTRIGUE Phase 3 clinical study of ripretinib and announcing plans to initiate INSIGHT.
In this webinar, “The Emerging Role of Circulating Tumor DNA in Gastrointestinal Stromal Tumor”, Dr. Bialick discussed recent data looking at treatment outcomes based off KIT resistant mutations identified by circulating tumor DNA in patients with GIST.
Dr. Ciara Kelly of Memorial Sloan Kettering Cancer Center at presented The Role of ctDNA in GIST at New Horizons 2019 in Wayne, NJ.